US-based healthcare technology company Komodo Health has introduced Marmot, an AI platform to transform patient care by delivering rapid healthcare analytics.
The AI platform is designed to provide life sciences and healthcare teams with insights within minutes, enhancing the development and delivery of therapies.
Its ability to integrate complex data allows healthcare teams to focus on strategic initiatives aimed at improving patient outcomes.
By leveraging Marmot, organisations can accelerate product development cycles and enhance therapeutic strategies, said Komodo.
Komodo Health co-founder and CEO Arif Nathoo said: “In a highly competitive environment, speed to insight is a critical differentiator.
“Built on our Healthcare Map with healthcare reasoning and pharmaceutical domain expertise engineered directly into the AI, Marmot fundamentally enhances analytical velocity, transforming complex questions that previously took weeks to answer into strategic, evidence-based insights in minutes.
“By designing Marmot to handle the complex analytical work, we’re creating space for Life Sciences teams to focus on strategic decisions that bring therapies to patients faster.”
Unlike generic AI models that may be rebuilt for healthcare, Marmot is specifically built for healthcare, leveraging Komodo Health’s extensive Healthcare Map.
The platform, covering over 330m de-identified patient journeys, allows Marmot to deliver accurate, regulatory-compliant insights that address traditional AI risks.
In addition, Alnylam Pharmaceuticals has partnered with Komodo Health to integrate Marmot into its operations through an enterprise agreement.
The collaboration will deploy custom AI agents in Alnylam’s key business functions to drive efficiency and innovation in pharmaceutical development.
Komodo Health co-founder and president Web Sun said: “Marmot demonstrates what’s possible when AI is built specifically for pharmaceutical insights workflows rather than retrofitted from generic consumer applications.
“By integrating seamlessly across Commercial and Medical Affairs operations while meeting the rigorous transparency and auditability standards that regulated industries require, Marmot doesn’t just deliver faster analytics, it gives Life Sciences teams the confidence to act on AI-generated insights.”
